Danaher Co. (NYSE:DHR) Shares Sold by Legacy Wealth Management LLC MS

Legacy Wealth Management LLC MS reduced its stake in shares of Danaher Co. (NYSE:DHR) by 5.9% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 13,345 shares of the conglomerate’s stock after selling 840 shares during the period. Danaher makes up approximately 1.2% of Legacy Wealth Management LLC MS’s portfolio, making the stock its 24th biggest holding. Legacy Wealth Management LLC MS’s holdings in Danaher were worth $3,063,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Teachers Insurance & Annuity Association of America acquired a new stake in shares of Danaher during the 3rd quarter valued at about $39,000. MidAtlantic Capital Management Inc. purchased a new position in Danaher in the 3rd quarter valued at $40,000. FSA Wealth Management LLC purchased a new stake in shares of Danaher during the third quarter worth $50,000. Darwin Wealth Management LLC acquired a new position in Danaher during the third quarter worth about $55,000. Finally, Dunhill Financial LLC boosted its holdings in shares of Danaher by 45.1% during the 3rd quarter. Dunhill Financial LLC now owns 222 shares of the conglomerate’s stock worth $62,000 after purchasing an additional 69 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 1.9 %

Shares of DHR stock traded up $4.40 during trading hours on Monday, reaching $239.24. The company had a trading volume of 589,507 shares, compared to its average volume of 1,775,952. The stock’s fifty day simple moving average is $236.37 and its 200 day simple moving average is $254.29. The company has a market capitalization of $172.80 billion, a P/E ratio of 45.66, a price-to-earnings-growth ratio of 4.33 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. Danaher Co. has a twelve month low of $222.53 and a twelve month high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter last year, the firm posted $2.02 earnings per share. As a group, sell-side analysts expect that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s dividend payout ratio is presently 20.61%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research report on Thursday, October 31st. Evercore ISI lifted their target price on Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Stifel Nicolaus raised their price target on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. Robert W. Baird lowered their target price on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Finally, Guggenheim assumed coverage on shares of Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective on the stock. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average price target of $287.05.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.